Detalhe da pesquisa
1.
Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope.
Cell
; 162(3): 493-504, 2015 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26189681
2.
Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees.
PLoS Pathog
; 8(8): e1002895, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22952447
3.
Identification of a human monoclonal antibody to replace equine diphtheria antitoxin for treatment of diphtheria intoxication.
Infect Immun
; 81(11): 3992-4000, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23940209
4.
Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein.
PLoS Negl Trop Dis
; 12(2): e0006209, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29425203
5.
Preclinical evaluation of VIS513, a therapeutic antibody against dengue virus, in non-human primates.
Antiviral Res
; 144: 44-47, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28529000
6.
G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates.
Antiviral Res
; 91(2): 187-94, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21693135
7.
Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates.
Vaccine
; 25(15): 2800-10, 2007 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-17240489